OPKO Health, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
OPKO Health, Inc. (OPK) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2025-03-03
- OPKO Health, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- OPKO Health, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $348.00K, a 28.41% increase from fiscal 2022.
- OPKO Health, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $271.00K, a 52.87% decline from fiscal 2021.
- OPKO Health, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $575.00K, a 135.66% increase from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-03 |
| 2023-12-31 | $348.00K 10-K · filed 2025-03-03 |
| 2022-12-31 | $271.00K 10-K · filed 2024-03-01 |
| 2021-12-31 | $575.00K 10-K · filed 2023-02-27 |
| 2020-12-31 | $244.00K 10-K · filed 2022-03-01 |
| 2019-12-31 | $298.00K 10-K · filed 2022-03-01 |
| 2018-12-31 | $7.60M 10-K · filed 2021-02-18 |
| 2017-12-31 | $1.72M 10-K · filed 2020-03-02 |
| 2016-12-31 | $671.00K 10-K · filed 2019-03-01 |
| 2015-12-31 | $176.00K 8-K · filed 2019-01-29 |
| 2014-12-31 | $396.00K 10-K · filed 2017-03-01 |
| 2013-12-31 | $589.00K 10-K · filed 2016-02-29 |
| 2012-12-31 | $472.00K 10-K · filed 2015-02-27 |
| 2011-12-31 | $420.00K 10-K · filed 2014-03-03 |
| 2010-12-31 | $1.41M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |